The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market size is expected to reach $5.88 billion in 2030 at a CAGR of 18.9%, driven by rising cell and gene therapy trials.
Read More
The Giant Papillary Conjunctivitis market size is expected to reach $1.06 billion in 2030 at a CAGR of 8.0%, driven by increasing use of contact lenses.
Read More
The Gene Therapy Bioassays market size is expected to reach $2.62 billion in 2030 at a CAGR of 16.7%, driven by rising gene therapy clinical trials.
Read More
The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market size is expected to reach $2.42 billion in 2030 at a CAGR of 32.9%, driven by rising myeloma prevalence.
Read More
The Frontotemporal Dementia market size is expected to reach $4.99 billion in 2030 at a CAGR of 9.0%, driven by growing adoption of precision medicine.
Read MoreThe Frontotemporal Dementia market size is expected to reach $4.99 billion in 2030 at a CAGR of 9.0%, driven by growing adoption of precision medicine.
Read More
The Fertility Tracking Sensor market size is expected to reach $3.32 billion in 2030 at a CAGR of 16.6%, driven by increasing infertility prevalence.
Read More
The Excessive Daytime Sleepiness market size is expected to reach $8.52 billion in 2030 at a CAGR of 9.6%, driven by rising prevalence of obstructive sleep apnea.
Read More
The Epitranscriptomic Therapies market size is expected to reach $4.2 billion in 2030 at a CAGR of 21.9%, driven by increasing demand for personalized medicine.
Read More
The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology market size is expected to reach $8.77 billion in 2030 at a CAGR of 23.5%, driven by rising adoption of genomics and personalized medicine.
Read More